CyberSecBulletin
CVE-2026-87356NVD status: Awaiting Analysis

Applications Platform Engineering: Exposure of Sensitive Information to an Unauthorized Actor

Published Updated By the CyberSecBulletin desk

CVE-2026-87356 is a high-severity exposure of sensitive information to an unauthorized actor vulnerability in Applications Platform Engineering from Oracle, with a CVSS 3.1 base score of 7.8 out of 10. It can be exploited with local access to the system by an attacker with a low-privileged account, without any action from a user. Affected Applications Platform Engineering versions: 12.2.3 through 12.2.15. The record does not name a fixed version, so check the vendor advisory. There is no confirmed exploitation so far. EPSS estimates a 0.15% chance of exploitation within 30 days, which is low compared with other CVEs.

Next patch cycle

High severity with no evidence of exploitation so far.

What to do

  1. Check which version of Applications Platform Engineering you run against the affected versions below, and install the vendor's latest release.

Affected products and versions

VendorProductAffected versionsFixed in
OracleApplications Platform Engineering12.2.3 through 12.2.15Not stated

Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.

How the severity score breaks down

Attack vector
LocalThe attacker needs local access or must trick a user into running something.
Attack complexity
LowNo special conditions are needed; the attack works reliably.
Privileges required
LowA basic user account is enough.
User interaction
NoneNo action by a victim is required.
Scope
UnchangedImpact stays within the vulnerable component.
Confidentiality
HighAll data handled by the component can be read.
Integrity
HighData or code can be modified at will.
Availability
HighThe component can be taken down completely.

Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. Scored by CNA (oracle.com).

Official description

Vulnerability in the Applications Platform Engineering product of Oracle E-Business Suite (component: Valid Session). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Applications Platform Engineering executes to compromise Applications Platform Engineering. Successful attacks of this vulnerability can result in takeover of Applications Platform Engineering. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

Source: the CVE record as published by its numbering authority, via NVD and CVE.org.

The underlying weakness: Exposure of Sensitive Information to an Unauthorized Actor

The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

How developers prevent this class of flaw

  • Compartmentalize the system to have safe areas where trust boundaries can be unambiguously drawn. Do not allow sensitive data to go outside of the trust boundary and always be careful when interfacing with a compartment outside of the safe area. Ensure that appropriate compartmentalization is built into the system design, and the compartmentalization allows for and reinforces privilege separation functionality. Architects and designers should rely on the principle of least privilege to decide the appropriate time to use privileges and the time to drop privileges.

More Exposure of Sensitive Information to an Unauthorized Actor vulnerabilities (CWE-200)

Timeline

  1. CVE record published.
  2. CISA published its SSVC assessment (exploitation: none, automatable: no, technical impact: total).
  3. Record last changed materially (score, affected products, status or references).

References

Other vulnerabilities in Applications Platform Engineering

All Applications Platform Engineering vulnerabilities

Recent Exposure of Sensitive Information to an Unauthorized Actor vulnerabilities

Spotted an error? Tell us.